Daotian Fu

President

Dr. Fu Daotian, our President, was previously the vice president and executive director of Livzon Pharmaceutical Group and also the general manager of Livzon MABPharm, Inc., a biologics development company. At Livzon, he led the biologics development efforts with one successful NDA submission and multiple programs in clinical development. Dr. Fu returned to China after spending 28 years working in the biopharmaceutical industry in the U.S. Between 1998 and 2012, he served as the vice president of R&D at Genzyme Corp., one of the top five global biotech companies (later acquired by Sanofi). During this period, Dr. Fu was responsible for CMC development of clinical stage programs, and was directly involved in global launching of five major biologics and clinical development of multiple R&D programs. Dr. Fu received his B.S. from Shandong University in China, and his Ph.D. from Iowa State University.